Lombard Odier Asset Management (USA)’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-75,000
Closed -$743K 402
2021
Q4
$743K Hold
75,000
0.03% 201
2021
Q3
$735K Buy
75,000
+59,800
+393% +$589K 0.03% 240
2021
Q2
$154K Buy
+15,200
New +$154K 0.01% 272

Other funds holding PROK

Lombard Odier Asset Management (USA)'s PROK Position: Q1 2022 in Review

Lombard Odier Asset Management (USA) sold out of ProKidney (PROK) in Q1 2022, closing a stake of 75,000 shares — an estimated $743K sold.

Lombard Odier Asset Management (USA) first reported a position in PROK in Q2 2021 and held it in 3 quarters. The position peaked at $743K in Q4 2021. 80 funds tracked by Wall St. Rank hold PROK as of Q1 2022.

  • Lombard Odier Asset Management (USA) reported no remaining ProKidney position as of Q1 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 75,000 ProKidney shares in Q1 2022, an estimated $743K.
  • Lombard Odier Asset Management (USA) first reported a position in ProKidney in Q2 2021 and held it in 3 quarters.
  • Lombard Odier Asset Management (USA)'s ProKidney position peaked at $743K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held ProKidney as of Q1 2022.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2022, filed 16 May 2022.